RICHMOND, Va., July 28 /PRNewswire-FirstCall/ -- Insmed Inc.
(Nasdaq: INSM), a biopharmaceutical company, today announced that
it will host a conference call on Wednesday,
August 4th, at 8:30 AM ET, to
discuss its financial results for the second quarter 2010.
Insmed intends to issue its quarterly financial results press
release before the market opens on August
4th.
To participate in the live conference call, please dial
866-783-2141 (U.S. callers) or 857-350-1600 (international), and
provide passcode 25517370. A live webcast of the call will
also be available at
http://phx.corporate-ir.net/playerlink.zhtml?c=122332&s=wm&e=3220391.
Please allow extra time prior to the webcast to register,
download and install any necessary audio software.
The webcast will be archived for 30 days, and a telephone replay
of the call will be available for seven days, beginning at
11:30 AM ET on August 4th, at 888-286-8010 (U.S. callers) or
617-801-6888 (international), using passcode 15200240.
About Insmed
Insmed Inc. is a biopharmaceutical company with unique protein
development experience and a proprietary protein platform aimed at
niche markets with unmet medical needs. For more information,
please visit http://www.insmed.com.
Forward-Looking Statements
This release contains forward-looking statements which are made
pursuant to provisions of Section 21E of the Securities Exchange
Act of 1934. Investors are cautioned that such statements in this
release, including statements relating to business strategies,
plans and objectives of management and our strategic review
process, constitute forward-looking statements which involve risks
and uncertainties that could cause actual results to differ
materially from those anticipated by the forward-looking
statements. The risks and uncertainties include, without
limitation, we may be unsuccessful in identifying or reaching
agreement with acquisition or merger candidates, our expenses may
be higher than anticipated and other risks and challenges detailed
in our filings with the U.S. Securities and Exchange Commission,
including our Annual Report on Form 10-K for the year ended
December 31, 2009. Readers are
cautioned not to place undue reliance on any forward-looking
statements which speak only as of the date of this release.
We undertake no obligation to publicly release the results of
any revisions to these forward-looking statements that may be made
to reflect events or circumstances that occur after the date of
this release or to reflect the occurrence of unanticipated
events.
Investor Relations
Contact:
|
|
Brian Ritchie –
FD
|
|
212-850-5683
|
|
brian.ritchie@fd.com
|
|
|
|
Media Contact:
|
|
Irma Gomez-Dib –
FD
|
|
212-850-5761
|
|
Irma.gomez-dib@fd.com
|
|
|
SOURCE Insmed Inc.